Denali Therap (DNLI.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec10

Denali Therapeutics Floats IPO to Raise $200 Million

23:42

Dec4

Denali Therapeutics and Royalty Pharma Reach $275 Million Financing Agreement

12:02

H.C. Wainwright Analyst Maintains Buy Rating on Denali Therapeutics with Price Target

08:02

Nov17

Stifel Nicolaus Analyst Maintains Denali Therapeutics Buy Rating

12:22

Nov11

BTIG Analyst Reiterates Buy Rating on Denali Stock

11:56

Nov10

Oppenheimer Analyst Reiterates Buy Rating for Denali Therapeutics

14:23

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -126.9 M, EPS -0.7359

Aug11

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -124.12 M, EPS -0.7239

May6

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -132.97 M, EPS -0.7765

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More